Spero Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.56

+0.05 (+1.99%)

As of May 16, 2:11 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,124.2% upside

Low Target $21.51

Average Target $31.34

High Target $48.77

Current Price $2.56

Current
$2.56

Target
$31.34

$21.51 $31.34 avg $48.77

Scenario Analysis

Bear Case

$21.51

740.2%

Low target

Base Case

$31.34

+1,124.2%

Avg target

Bull Case

$48.77

+1,805.1%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$3.22

-20.5% from high

52-Week Low

$0.63

+307.8% from low

Target vs 52W High

$31.34

+873.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%